Medical Technology

@xconomy.com 3 years ago

Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More

@xconomy.com 4 years ago

Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More

@xconomy.com 4 years ago

Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More

@xconomy.com 4 years ago

PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome

@xconomy.com 5 years ago

With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes

@xconomy.com 5 years ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

@xconomy.com 5 years ago

Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans

@xconomy.com 5 years ago

Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans

@xconomy.com 5 years ago

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

@xconomy.com 5 years ago

Magnolia Medical Captures $20M to Reduce Blood Culture Contamination

@xconomy.com 5 years ago

Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel

@xconomy.com 5 years ago

Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More

@xconomy.com 5 years ago

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

@xconomy.com 5 years ago

Renovia Raises $42M to Back Digital Treatment for Incontinence

@xconomy.com 6 years ago

Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More